DEXTRAIN
Business purpose.
Conception, développement et commercialisation de dispositifs médicaux et de logiciels informatiques en matière de santé. Création, édition, exploitation et administration de plateformes en ligne et de sites internet dans le domaine médical. Exploration de données touchant à la santé et traitement des données collectées. Recherche-développement en matière de santé. Produits, conseils et services accessoires.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Other research and experimental development on natural sciences and engineering (72.19Z)
- Sector
- Scientific research and development
- Headcount
- 1 to 2 employees
- Created
- 17 Feb 2021
- Share capital
- 21,062.60 EUR
- Registered with the trade register
- 19 Feb 2021
- Financial year end
- 31/12
- Establishments
- 2
Directors
- LOIC GEORGES YVES POIRIER 57 years old, 06/1969 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- POLADERME via LOIC GEORGES YVES POIRIER
- LIFI MED via LOIC GEORGES YVES POIRIER
- ARDOIZ via LOIC GEORGES YVES POIRIER
- DEEP TECH INVEST via LOIC GEORGES YVES POIRIER
Other companies at the same address
10 other company head offices are registered at this address.
Establishments
-
89428461100015 91430 IGNY
Financial strength
Financial score
20 / 100 E
Confidence: medium · computed on the financial year ended 31 Dec 2024
- Equity to assets (0.0 %)
- 4.1 out of 30
- EBITDA margin (-3,980.9 %)
- 0.0 out of 25
- Liquidity (48.9 %)
- 1.1 out of 20
- Debt (0.0 %)
- 15.0 out of 15
- Revenue trend (-33.0 %)
- 0.0 out of 10
formula fin-1.0
Legal score
91 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (5.7 years)
- 11.5 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 7,500 € | -33.0 % | -298,567 € | -339,049 € |
| 31 Dec 2023 | 11,200 € | -92.0 % | -226,621 € | -224,625 € |
| 31 Dec 2021 | 139,320 € | first year on record | -13,198 € | 53,717 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale des bureaux d'études techniques, des cabinets d'ingénieurs-conseils et des sociétés de conseils du 15 décembre 1987.
IDCC 1486 · in force, extended · 1 establishment · declared in July 2026
Legal notices
-
Amendment 30 Sep 2025
- Court :
- Greffe du Tribunal de Commerce d'Evry
- Amendment :
- Modification survenue sur l'activité, transfert du siège social.
BODACC B n 20250187, annonce n 4528 · Proof of publication (PDF)
-
Filing of accounts 26 Sep 2025
- Court :
- Greffe du Tribunal de Commerce d'evry
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250185, annonce n 5438 · Proof of publication (PDF)
-
Filing of accounts 14 Feb 2025
- Court :
- Greffe du Tribunal de Commerce d'evry
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20250032, annonce n 3704 · Proof of publication (PDF)
-
Amendment 26 Dec 2023
- Court :
- Greffe du Tribunal de Commerce d'Evry
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20230249, annonce n 2904 · Proof of publication (PDF)
-
Amendment 2 Jul 2023
- Court :
- Greffe du Tribunal de Commerce d'Evry
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20230126, annonce n 2781 · Proof of publication (PDF)
-
Amendment 6 Jun 2023
- Court :
- Greffe du Tribunal de Commerce d'Evry
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20230107, annonce n 2866 · Proof of publication (PDF)
-
Filing of accounts 6 Oct 2022
- Court :
- Greffe du Tribunal de Commerce d'evry
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220194, annonce n 12584 · Proof of publication (PDF)
-
Incorporation 23 Feb 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE D'EVRY
BODACC A n 20210037, annonce n 1215 · Proof of publication (PDF)
Filings and accounts
- Formality 26 Sep 2025
Change history
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital 18498.50 → 10000.00 3 Oct 2026
- capital 14225.00 → 18498.50 3 Oct 2026
- capital 21062.60 → 14225.00 3 Oct 2026
- registered_address 12 Rue Ampère 91430 Igny → 3 Rue Ampère 91430 Igny 2 Oct 2026
- registered_address (empty) → 12 Rue Ampère 91430 Igny 1 Oct 2026
- capital (empty) → 21062.60 1 Oct 2026
Frequently asked questions about DEXTRAIN
- What is the SIREN number of DEXTRAIN?
- The SIREN number of DEXTRAIN is 894284611. Its intra-community VAT number is FR06894284611.
- Where is the head office of DEXTRAIN?
- Head office address: 3 RUE AMPERE, 91430 IGNY.
- When was DEXTRAIN founded?
- DEXTRAIN was founded on 17 Feb 2021.
- What does DEXTRAIN do?
- Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
- Who runs DEXTRAIN?
- The officer listed in the register is LOIC GEORGES YVES POIRIER (President de SAS).
- What is the revenue of DEXTRAIN?
- The latest published revenue is 7,500 €, for the 2024 financial year.
- How many employees does DEXTRAIN have?
- The declared headcount is 1 to 2 employees. Insee data for 2024.
- Is DEXTRAIN subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.